Skip to content

MARIA19-09T

Effects of resistant starch brown rice on glucose metabolism in patients with type 2 diabetes.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031200008
Enrollment
30
Registered
2020-04-10
Start date
2020-05-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

For breakfast, subjects ingest 150g of OIST rice or white rice on separate days after overnight fast. Each test day has an interval of 1-3 days.

Sponsors

Nakamura Yuta
Lead Sponsor
NICHIREI CORPORATION
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are admitted to the Department of Metabolism and Endocrinology, St. Marianna University Hospital for improvement of glycemic control and meet the following criteria. 1. Patients with insulin-independent type 2 diabetes mellitus ; fasting serum C-peptide>=0.6 ng/ml and GAD antibody negative. 2. Patients with a fasting blood glucose level of 54-300 mg/dL during the last 3 days. 3. Male or female over the age of 20 at the time of obtaining informed consent. 4. Patients who agreed to use the data of urine and blood tests ; Hgb, Hct, blood glucose, AST, ALT, Cre, BUN, UA, T-chol, HDL-chol, LDL-chol, TG, HbA1c, GA, C-peptide, urinary microalbumin. 5. Patients with written informed consent after receiving a full explanation.

Exclusion criteria

Exclusion criteria: 1.Patients using any of the following diabetes treatments. /DPP4 inhibitor /GLP-1 receptor agonist /alpha-glucosidase inhibitor 2.Patients who need more than 15 units of rapid-acting insulin in the morning when obtaining informed consent. 3.Patients with unstable oral intake. 4.Women who were pregnant, possibly pregnant, or were breastfeeding. 5.Menstrual period. 6.Rice allergy or brown rice allergy. 7.Patients who were considered to be ineligible for other reasons by the attending doctor.

Design outcomes

Primary

MeasureTime frame
total AUC0-240min - glucose

Secondary

MeasureTime frame
incremental AUC0-240min - glucose total AUC0-240min - insulin incremental AUC0-240min - insulin total AUC0-240min - total GLP-1 incremental AUC0-240min - total GLP-1 total AUC0-240min - total GIP incremental AUC0-240min - total GIPpreference questionnaire

Contacts

Public ContactYuki Ohta

St. Marianna University School of Medicine

yuki-o@marianna-u.ac.jp+81-44-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026